BIOMAT Database Logo BIOMAT Database Logo

Driving and intrathecal morphine administration. 2001

G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Laboratory of Medical Biochemistry and Toxicology, Algemeen Centrumziekenhuis Antwerpen, Campus Stuivenberg, Lange Beeldekensstraat 267, Antwerp, 2020, Belgium.

Since Belgian law recently set a limit to morphine concentration detectable in blood and urine while driving a vehicle, questions arose about the implications for the medical use of opiates. We determined morphine concentrations in whole blood and urine by gas chromatography-mass spectrometry in 15 patients on continuous intrathecal morphine administration. Effects on blood and urine concentration after water intake and the correlation with the intrathecal morphine daily dose were also evaluated. Our results confirm that, in all patients examined, the legally determined maximum blood morphine concentration of 20 ng/ml was never exceeded. Even patients on high intrathecal morphine dose schedules did never reach the maximum legal blood concentration. However, morphine concentration in urine reached levels which exceeded by far the legally determined maximum concentration of 300 ng/ml. Although legal actions against driving under the influence of morphine can only be taken after a positive urine and a subsequent positive blood sample, drivers on intrathecal opiates must be aware of the possibility of a positive roadside drug test.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D001334 Automobile Driving The effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical disabilities on driving. Automobile Drivings,Driving, Automobile,Drivings, Automobile

Related Publications

G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Nystagmus following intrathecal morphine administration.
January 1993, Journal of anesthesia,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Intrathecal administration of drinking water and morphine.
January 2006, Journal of palliative care,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Teaching family members intrathecal morphine administration.
April 1986, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
[Intrathecal morphine administration for oral and maxillofacial malignomas].
January 1990, Deutsche zahnarztliche Zeitschrift,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Plasma morphine concentration after intrathecal administration of low doses of morphine.
October 1981, British journal of anaesthesia,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
[Prolonged administration of morphine via the intrathecal route].
January 1985, Cahiers d'anesthesiologie,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Tolerance during long-term administration of intrathecal morphine.
May 1989, Connecticut medicine,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
[Chronic intrathecal administration of morphine for cancer pain].
January 1987, Revista espanola de anestesiologia y reanimacion,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Opiate withdrawal syndrome following intrathecal administration of morphine.
October 1980, Anesthesiology,
G Van den Bosch, and M De Doncker, and P Vercruysse, and J Maeyaert, and K Vissers, and H Neels
Narcotic withdrawal syndrome after intrathecal administration of morphine.
August 1981, British medical journal (Clinical research ed.),
Copied contents to your clipboard!